Tag #Chinese Biotech

Showing 1 to 2 of 2 results

cnn.com
🌐 85% Global Worthiness
News related image

Chinese Biotech Drug Outperforms Keytruda in Clinical Trials

Akeso's new lung cancer drug, Ivonescimab, outperformed Merck's Keytruda in Chinese clinical trials, extending progression-free survival; this success, coupled with increased licensing deals, highlights the rise of China's pharmaceutical innovation, though challenges in consumer trust and regulatory...

Progress

48% Bias Score

Good Health and Well-being
edition.cnn.com
🌐 85% Global Worthiness
News related image

Chinese Biotech Drug Outperforms Keytruda in Clinical Trials

Akeso, a Chinese biotech company, developed Ivonescimab, a lung cancer drug that outperformed Merck's Keytruda in clinical trials, resulting in a stock surge for its US partner and showcasing China's rising pharmaceutical innovation.

Progress

40% Bias Score

Good Health and Well-being

Showing 1 to 2 of 2 results